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Abstract NK cell cytotoxicity (NKCC) reduces with
age and this has been associated previously with in-
creased mortality. The immune response is also modu-
lated by stress, and here, we assessed the effect of the
physical stress of hip fracture and the psychological
stress of depression on NKCC in an aged immune
system. NKCCwas assessed in 101 hip fracture patients
(81 female) 6 weeks and 6 months after injury and in 50
healthy age-matched controls (28 female). Thirty-eight
patients were depressed at 6 weeks post-injury, and
NKCC was reduced in patients who developed depres-
sion compared with non-depressed hip fracture patients
(p=0.004) or controls (p<0.02). NKCC remained lower
in the depressed patients compared to those without
depression 6 months post-fracture (p=0.017). We found
reduced expression of perforin in NK cells of depressed
hip fracture patients compared with controls at 6 weeks
(p=0.001) post-fracture. Serum cortisol levels were
also elevated in patients with depression compared to
non-depressed patients at 6 weeks (p=0.01) and
6 months (p=0.05). NK cells treated with dexameth-
asone showed a concentration-dependent reduction in
NKCC and perforin expression. We propose that
depression is the major factor affecting NK cell immu-
nity after hip fracture.
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Introduction
Hip fracture is one of the most frequent physical traumas
in older adults with an estimated 370,000 over 65 year
olds falling every year in the UK alone, and the resulting
number of hip fractures is predicted to rise to 120,000 by
2015 (Johnell et al. 1992). Even though hip fracture is
treatable, it has a devastating effect on the life of older
individuals and has been associated with poor out-
comes: one in four patients die within a year of their
fracture (Haentjens et al. 2007) and less than 30 % of
patients return to their previous level of functioning
(Jette et al. 1987).
Ageing is also accompanied by psychological dis-
tress and behavioural alterations; for instance, a high
prevalence of depression has been reported in older
adults (Ritchie et al. 2004). In addition, physical
stress is a frequent precipitator of depression and a
high rate of depression ranging from 9 to 47 % has
been reported in older hip fracture patients (Holmes
and House 2000). Depression in this patient popula-
tion has a substantial effect on their post-fracture
survival (Nightingale et al. 2001) and functional
outcome (Holmes and House 2000).
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It is now well established that a decline in immune
function occurs with age, termed immunesenescence
(Meyer 2005; Panda et al. 2009), resulting in an in-
creased risk of infections, reduced vaccination re-
sponses and chronic illnesses (Castle 2000; Meyer
2005). Immunesenescence is evident in both the adap-
tive and innate arms of the immune system and several
groups, including our own, have reported a decline in
the function of NK cells (Di Lorenzo et al. 1999;
Hazeldine et al. 2012). These cells play a key role in
anti-viral and anti-cancer immunity, and although with
age the numbers of these cells increase, their cytotoxic
function declines (Almeida-Oliveira et al. 2011; Sansoni
et al. 1993). NK cells kill virus-infected cells and
cancer cells via ligation of death receptors and also
by release of a pore-forming agent perforin and the
apoptosis-inducing molecule granzyme (Smyth et al.
2005). Perforin creates pores in the target cell mem-
brane allowing entry of granzyme which then in-
duces caspase-dependent apoptosis (Law et al.
2010; Trapani and Smyth 2002). We have shown
recently that the reduced cytotoxicity with age is
due to reduced release of perforin from NK cells
(Hazeldine et al. 2012).
The immune system does not operate in isolation,
and a range of chronic stressors such as bereavement
(Phillips et al. 2006), relationship stress (Kiecolt-Glaser
et al. 2005), caregiving (Kiecolt-Glaser et al. 1996) and
depression (Zorrilla et al. 2001) have been shown to
suppress immune responses. In particular, the work of
Kiecolt-Glaser and colleagues has shown that NK
cells are susceptible to stress, with reduced NK cell
cytotoxicity seen in caregivers (Esterling et al. 1996).
Psychological stress may therefore exacerbate the
suppressive effect of age on immune functioning,
such that older individuals experiencing chronic
stress are less able to mount successful immune
responses (Graham et al. 2006). This is supported by
work in stressed aged mice which have been shown to
have reduced NK cell activity and lower survival com-
pared to young stressed mice (Padgett et al. 1998).
Chronic stress-associated immune suppression in older
adults has clinical consequences, including an increased
risk of bacterial and urinary infections in older adults
post-surgery compared to young patients matched for
clinical trauma level (Butcher et al. 2003).
A hallmark of the neuroendocrine immune response
to stress is the activation of the hypothalamus-pituitary-
adrenal (HPA) axis (Smith and Vale 2006) leading to
increased circulating levels of immune suppressive
glucocorticoids (Tsigos and Chrousos 2002).
Glucocorticoids such as cortisol suppress the activity of
many immune cells, includingNK cells (Krukowski et al.
2011). Dehydroepiandrosterone sulphate (DHEAS),
which is also produced by the adrenal gland, has been
reported to have anti-depressive, anti-glucocorticoid
and immune-enhancing properties (Hazeldine et al.
2010). Ageing is accompanied by changes to the
HPA axis termed the adrenopause, associated with
reduced DHEAS (Orentreich et al. 1984; Parker
et al. 1997) and unaltered or slightly raised levels of
cortisol (Pedersen et al. 2001). This results in an age-
associated heightened HPA axis response with eleva-
tion in the cortisol/DHEAS ratio which could contrib-
ute to further immune dysregulation in older adults
(Butcher et al. 2005).
In this study, we hypothesised that psychological
stress, specifically depression, would act additively with
the physical stress of hip fracture to amplify the effect of
ageing upon immunity (immunesenescence), with spe-
cific reference to NK cell cytotoxicity.
Results
Depressive symptoms in patients and controls
The full demographic statistics for the participants in the
study have been reported previously (Phillips et al.
2013). The key data for this study relate to the level of
depressive symptomatology. Depressive symptoms in
hip fracture patients and controls were measured using
the Geriatric Depression Scale. Four to 6 weeks after
their hip fracture, 38 of the 101 hip fracture patients
recruited had GDS scores of 6 or more, indicative of
depression. None of the age-matched healthy controls
had scores of 6 or more. Patients were classified into two
groups on the basis of their GDS scores: hip fracture
patients with a GDS score of 5 or less were classified as
non-depressed (HF; hip fracture only), those with a
score of greater than 6 or more were categorised as
depressed (HF +D; hip fracture patients with depression).
The healthy controls were slightly younger (74.9±5.63)
than the hip fracture group without depressive symptoms
(83.9±7.48) and hip fracture group with depressive
symptoms (84.0±8.62), and as a result, all data were
adjusted for age in the statistical analyses.
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The composition of the circulating NK cell pool in hip
fracture patients
There were no significant differences in the percentage
of NK cells in the PBMC pool F(2, 108)=.95, p=0.38,
η2=.01, or the absolute numbers of NK cells F(2,
55)=.47, p=0.62, η2=.01 (Table 1) between the
three subject groups. Further, on examining the dis-
tribution of the two NK cell subsets—CD56dim and
CD56bright—we found no difference in the percent-
age of CD56dim NK cells, F(2, 133)=2.52, p=0.08,
η2=.03, or of CD56bright NK cells, F(2, 133)=1.84,
p=0.16, η2=.02 between hip fracture patients with and
without depression and healthy controls (Table 1).
Therefore, the CD56dim/bright ratio also did not differ
between the three subject groups, F(2, 133)=1.95,
p=0.14, η2=.03 (Table 1).
CD57 expression on NK cells is suggestive of a
mature terminally differentiated phenotype with de-
creased proliferation and reduced responsiveness to cy-
tokines (Lopez-Verges et al. 2010). The percentage of
NK cells expressing CD57 F(2, 54)=1.31, p=0.27,
η2=.04 and the CD57 expression levels F(2, 54)=.12,
p=0.88, η2=.004 also did not differ between the three
groups (Table 2). Next, we evaluated the expression of
CD16 on NK cells of hip fracture patients as an indica-
tion of their potential to carry out antibody-dependent
cell cytotoxicity (ADCC). The percentage of NK cells
expressing CD16 F(2, 44)=1.06, p=0.35, η2=.04 and
the expression levels F(2, 44)=.59, p=0.55, η2=.02 did
not differ between the three groups (Table 2). A
range of activation receptors expressed by NK cells
are involved in recognising ligands on tumour cells
and have been associated with NK cell cytotoxicity
(Moretta et al. 2006). Evaluation of the expression of
activating receptor NKG2D on NK cells revealed
that the percentage of NK cells expressing NKG2D
F(2, 42)=.67, p=0.51, η2=.03 and the expression
levels F(2, 42)=.97, p=0.38, η2=.04 did not differ
between the three groups (Table 2).
NK cell cytotoxicity in hip fracture patients
The major mechanism utilised by NK cells to mediate
protection against virally infected or tumour cells is via
direct cell lysis of target cells. We found that NKCC
towards K562 target cells differed between the groups,
F(2, 114)=5.55, p=0.004, η2=.08 (Fig. 1b), but the
impairment was restricted to the hip fracture patients
who developed depression, p=0.01, compared to con-
trols, and p=0.004, compared to hip fracture alone.
When all of the above analyses were repeated with
adjustment for age, the results remained the same (data
not shown). Further, we found an association between
NK cell cytotoxicity and depressive symptoms in hip
fracture patients, r(78)=−.355, p=0.001 (Fig. 1c), sug-
gesting that the higher the GDS (depression) score, the
lower the NK cell cytotoxicity.
Conjugate formation and expression of cytotoxic
proteins by NK cells in hip fracture patients
The induction of NK cell cytotoxicity is dependent on
cell contact between NK cells and target cells to ensure
precise targeting of the cytolytic protein perforin to the
target cell (Orange 2008). In this study, we did not find
any significant differences in the ability of NK cells to
form conjugates with K562 target cells between the
Table 1 NK cell subsets in hip fracture patients 6 weeks post-fracture
Mean (SD)
Variable Controls Hip fracture patients (HF) Hip fracture patients with depressive
symptoms (HF + D)
p value
NK cells (% of PBMCs) 12.74 (7.58) 14.66 (6.99) 15.32 (8.70) .32
NK cell absolute numbers (109/ml) .18 (.08) .17 (.09) .26 (.24) .14
CD56dim NK (% of PBMCs) 14.32 (6.68) 14.70 (7.57) 13.41 (7.12) .76
CD56dim NK cell numbers (109/ml) .18 (.08) .18 (.08) .19 (.15) .94.
CD56bright NK (% of PBMCs) .67 (.44) .58 (.40) .59 (.37) .63
CD56bright NK cell numbers ( 109/ml) .01 (.02) .006 (.003) .01 (.01) .44
CD56 dim/bright ratio 45.43 (28.31) 34.37 (29.06) 39.81 (24.94) .52
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healthy controls and hip fracture patients with andwithout
depression F(2, 72)=.41, p=0.66, η2=.01 (Fig. 2a). Cell
conjugate formation is a dynamic process involving ad-
hesion molecules, and engagement of lymphocyte
function-associated antigen 1 (LFA-1) by its ligand
ICAM-1 on target cells is a central step in stable adhesion
of NK cells to their target cells and is essential for NK cell
cytotoxicity (Matsumoto et al. 2000). On examining
LFA1 expression between the three groups, we also found
no difference between groups F(2, 37)=.15, p=0.85,
η2=.009 (Fig. 2b); further supporting the conclusion that
impaired NK cell cytotoxicity of depressed hip fracture
patients was not a result of reduced conjugate formation.
Perforin and granzyme are the main constituents of
cytotoxic granules that are responsible for inducing target
cell death. Perforin is a multidomain protein that
oligomerises to form pores in the target cell membrane
facilitating delivery of granzymes into the cytosol of target
cells (Law et al. 2010). Immunostaining to measure
perforin expression by NK cells revealed significant
differences between the three groups, F(2, 75)=7.89, p=
0.001, η2=.17, with the reduction in perforin expression
restricted to the hip fracture patients with new onset de-
pression compared to controls, p<0.001 (Fig. 2c). Even
though perforin expression on NK cells of hip fracture
patients without depressive symptoms was lower than
healthy controls, this difference was not statistically signif-
icant, p=0.16. Granzymes are serine proteases responsible
for triggering target cell death via direct caspase activation
and triggering mitochondrial permeabilisation (Cullen and
Martin 2008). On examining intracellular granzyme B
expression byNK cells, we did not observe any significant
differences in expression levels in NK cells, F(2, 55)=.16,
p=0.84, η2=.006 (Fig. 2d) between the three groups.
Serum cortisol and DHEAS levels in hip fracture
patients
Analysis of cortisol levels after 6 weeks revealed signif-
icantly higher serum cortisol levels in hip fracture
Table 2 NK cell phenotypic characterisation in patients 6 weeks post-hip fracture
Mean (SD)
Variable Controls Hip fracture patients (HF) Hip fracture patients with depressive
symptoms (HF + D)
p value
CD57+ve NK cells (% of NK cells) 52.17 (13.46) 49.79 (16.53) 57.59 (14.90) .27
CD57 expression (MFI) 166.56 (81.68) 163.74 (85.49) 191.91 (117.96) .60
CD16+ve NK (% of NK cells) 79.52 (13.97) 85.34 (9.81) 85.76 (13.91) .34
CD16 expression (MFI) 201.56 (44.37) 207.02 (70.95) 225.70 (96.96) .65
NKG2D+ve NK (% of NK cells) 91.53 (4.66) 93.47 (5.78) 92.70 (4.32) .47
NKG2D expression (MFI) 25.70 (4.11) 29.32 (5.78) 37.84 (40.10) .36
a b
r (78) = -.314 
p= .005
*
**n.s
Fig. 1 NK cell cytotoxicity in hip fracture patients. a Flow cy-
tometry analysis of NKCC and conjugate formation by post-cul-
ture immunostaining of effector and target co-cultures with CD56-
PE for identification of NK cells and K562 cells. b NKCC of
healthy elderly controls and hip fracture patients with and without
depression (healthy controls: n=34; hip fracture patients without
depression (HF): n=38; hip fracture patients with depression
(HF+D): n=26). The mean value is indicated by the bar.
*p<0.005; **p<0.001. c Correlation between GDS depression
scores and NK cell cytotoxicity
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patients with depressive symptoms (0.17±0.05 mg/ml)
compared with healthy controls (0.13±0.04 mg/ml; p=
0.006) or with hip fracture patients without depression
(0.12±0.04 mg/ml; p<0.001). By 6 months, the cortisol
levels were still significantly raised in the depressed
group (0.14±0.04 mg/ml) compared with hip fracture
patients without depression (0.11±0.03 mg/ml;
p<0.01). Further, a significant association was found
between serum cortisol levels and NKCC in hip fracture
patients, β=−.25, p=0.02, ΔR2=.06 (Fig. 3), but not
with NK cell perforin expression (p=0.76). DHEAS
levels were also significantly lower after 6 weeks in
hip fracture patients with depressive symptoms (0.17±
0.14 mg/ml) compared with healthy controls (0.81±
0.36 mg/ml; p<0.001) and the hip fracture alone group
(0.43±0.80 mg/ml; p=0.008). Also, DHEAS levels of
hip fracture patients without depression were signifi-
cantly lower than healthy controls (p=0.03). However,
serum DHEAS did not relate to NKCC (p=0.58) or
perforin expression (p=0.30). Also by 6 months after
injury serum, DHEAS levels did not significantly differ
between hip fracture patients with (0.23±0.22 mg/ml)
and without (0.27±0.20 mg/ml) depressive symptoms
(p=0.14).
Testing for mediation of depression effects on NK cell
function by cortisol
In order to test whether the group differences in cortisol
were driving the group differences in NKCC, a series of
linear regression models were run. Age was entered into
the model at block 1 as a covariate followed by group
(depressed hip fracture, non-depressed hip fracture,
healthy controls) with NKCC as the dependent variable.
As expected, group significantly predicted NKCC,
β=−.27, p=0.01, ΔR2=.06, such that the lowest
killing ability was observed among the depressed
group as previously. On its own, cortisol also predicted
NKCC, β=−.23, p=0.02, ΔR2= .05, as expected.
However, when cortisol was also entered into the model
at step 2 as a potential mediator, the association between
group andNKCC remained significant, β=−.23, p=0.03,
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Fig. 2 Conjugate formation and cytotoxic protein expression in
hip fracture patients. a NK cell and target cell conjugate formation
of healthy elderly controls and hip fracture patients with and
without depression (healthy controls: n=28; hip fracture patients
without depression (HF): n=22; hip fracture patients with depres-
sion (HF+D): n=22). The mean value is indicated by the bar. b
Surface expression of adhesion molecule LFA-1 on NK cells of
healthy elderly controls (n=15), hip fracture patients without
depression (n=15) and depressed hip fracture patients (n=15). c
Perforin expression by NK cells from hip fracture patients with
depression (n=26), hip fracture patients without depression
(n=26) and healthy controls (n=26). d Granzyme B expres-
sion by NK cells from hip fracture patients with depression
(n=20), hip fracture patients without depression (n=20) and
healthy controls (n=20). *p<0.001
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ΔR2=.04, suggesting that cortisol was not directly
mediating the link between participant group and
NKCC, though it could contribute separately to
depression and reduced NKCC after hip fracture.
Treatment with dexamethasone suppresses NK cell
killing in vitro
Glucocorticoids are known to exert a suppressive effect
on NK cell killing (Holbrook et al. 1983; Krukowski
et al. 2011). As we found increased serum cortisol levels
correlated with reduced NKCC in the cohort of patients
studied here, the possible involvement of cortisol was
investigated further (Duggal et al. 2013). We performed
an in vitro incubation of NK cells with dexamethasone
(a synthetic glucocorticoid), for 18 h prior to an NKCC
assay with K562 cells. Dexamethasone treatment result-
ed in a dose-dependent reduction in NK cell lysis of
K562 cells (Fig. 4a) at 10−5 M dexamethasone
(p<0.001) and 10−7 M (p<0.04) compared to untreated
NK cells, but not at 10−9 M (p=0.90). 10−7 M dexa-
methasone is equivalent to the physiological serum cor-
tisol levels observed in hip fracture patients and has
been referred to as a physiological concentration of
dexamethasone in previous studies (Bush et al. 2012;
Krukowski et al. 2011).
To exclude the possibility that suppressed NK cell
killing seen at 10−7 M dexamethasone was caused by
increased apoptosis of NK cells, we stained NK cells
incubated for 18 h for Annexin V and sytox blue.
There was no significant difference in the percentage
of Annexin V-positive NK cells between untreated
cells and NK cells treated with 10−7 M dexamethasone,
F(1, 8)=.09, p=0.77, η2=.01 (data not shown).
On analysing the ability of NK cells to form conju-
gates with K562 target cell after dexamethasone
treatment, we found no significant differences in the
ability of NK cells to form conjugates, F(3, 24)=.15,
p=0.92, η2=.02 (Fig. 4b). We also found no effect of
dexamthasone on CD69 expression, F(1, 8)= .12,
p=0.72, η2=.01 (Fig. 4c), or induction of CD107a,
F(3, 24)=.85, p=0.47, η2=.09 (Fig. 4d). In contrast,
when we examined perforin expression by NK cells
following dexamethasone treatment, we found that the
expression of perforin was significantly reduced by
treatment with 10−5 M dexamethasone (p=0.001) and
10−7 M (p>0.04) (Fig. 5a). Additionally, granzyme B
expression levels were also measured on NK cells after
dexamethasone treatment, but we did not observe any
significant differences in the percentage of NK cells
expressing granzyme B, F(3, 16)= .03, p=0.99,
η2=.007 (data not shown), or the granzyme expression
levels, F(3, 16)=.03, p=0.99, η2=.006 (Fig. 5b).
Recovery of NK cell cytotoxicity in hip fracture patients
6 months after surgery
On comparing NK cell cytotoxicity in hip fracture pa-
tients with and without depression at 4–6 weeks and
6 months post-surgery, there was no significant effect of
time, F(1,40)=1.53, p=0.22, η2=.03, such that the NK
cell activity did not change overall with time (Fig. 6a).
There was still a significant effect of group on NK cell
activity, F(1, 40)=3.14, p=0.04, η2=.07, such that the
NK cell activity of depressed hip fracture patients was
reduced compared to healthy controls even 6 months
after surgery. We also compared perforin expression in
the NK cells of depressed hip fracture patients with and
without depressive symptoms 6 weeks and 6 months
post-surgery, but there was no significant effect of time,
F(1, 13)=.27, p=0.61, η2=.021 (Fig. 6b) such that
perforin expression in NK cells did not improve even
6 months post-injury in depressed hip fracture patients.
Discussion
Natural killer cells provide immune defence against
viral infections and tumours (Cerwenka and Lanier
2001). An age-associated increase in NK cell number
(Borrego et al. 1999; Sansoni et al. 1993) and CD56dim/
bright ratio (Chidrawar et al. 2006; Gayoso et al. 2011)
alongside a decline in NK cell cytotoxicity has beenwell
documented (Camous et al. 2012; Hazeldine et al.
2012). Additionally, numerous studies have reported a
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Fig. 3 Relationship of serum cortisol to NKCC. Serum cortisol
for healthy controls (n=34) and hip fracture patients (n=64) were
correlated with values for NKCC
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suppressive effect of severe life stressors such as care-
giving (Irwin et al. 1987b), bereavement (Gerra et al.
2003; Irwin et al. 1988; Kiecolt-Glaser et al. 1987) and
occupational stress (Boscolo 2009; Boscolo et al. 2009)
on NK cell activity. Here, we report for the first time that
the combination of hip fracture and depression results in
further suppression of the age-related decline in NK cell
activity. Crucially, our data show that hip fracture alone
did not affect NK cell function, and it was only the
addition of the psychological distress of depression that
induced further loss of NK cell activity.
Our findings are consistent with previous reports of
suppressed NK cell cytotoxicity in depressed individ-
uals (Irwin et al. 1990; Jozuka et al. 2003; Kronfol et al.
1989; Maes et al. 1994), and the literature also supports
our conclusion that this suppression in NK cell cytotox-
icity in depressed patients is not a result of alterations in
numbers of circulating NK cells (Darko et al. 1988;
Maes et al. 1994) or a result of alterations in CD56dim/
CD56bright NK cell distribution or CD16+ve NK cells.
Interestingly, we have also found an association be-
tween depression scores and NK cell cytotoxicity in
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Fig. 4 Effect of in vitro
dexamethasone treatment on NK
cell cytotoxicity. NK cells were
treated with varying
concentrations of dexamethasone
for 16 h. a NKCC or b NK cell-
target cell conjugate formation
values for healthy donors (n=9)
treated with dexamethasone
(10−5, 10−7 and 10−9 M) are
shown. Data are mean±SEM.
*p<0.05; **p<0.001. c The
percentage of CD69+ NK cells in
dexamethasone treated and
untreated cells (control) for n=5
donors. d Flow cytometric plots
of the percentage of
CD3−veCD56+ve NK cells
expressing CD107a following
stimulation with K562 cells, in
the absence of presence of
dexamethasone (107 M)
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Fig. 5 Perforin and granzyme B expression by NK cells post-
dexamethasone treatment. a Perforin expression (MFI) by NK
cells from young donors upon treatment with dexamethasone at
the concentration shown. Data are mean±SEM (n=8). b
Granzyme B expression (MFI) by NK cells on treatment with
dexamethasone at the concentrations shown. Data are mean±
SEM (n=5). *p<0.05; **p<0.001
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hip fracture patients, which has been reported in people
undergoing severe life stressors, such as bereavement
(Irwin et al. 1987a). Reduced NK cell cytotoxicity has
been associatedwith an increased incidence and reduced
survival during viral infections (Levy et al. 1991).
Furthermore, epidemiological data has suggested an
association between depressive symptoms and in-
creased cancer morbidity and mortality (Shekelle et al.
1981). Taken together, these data suggest that the im-
pairment in NK cell activity of depressed hip fracture
patients might be of clinical significance and have im-
plications for the health of these patients helping to
explain in part the high 1-year mortality in this patient
group (Nightingale et al. 2001).
Even though a number of studies have reported im-
paired NK cell activity on chronic exposure to psycho-
logical distress, none of these studies have tried to
explain the reason behind this impaired killing by NK
cells. In an attempt to examine the mechanism behind
suppressed NK cell cytotoxicity, we first investigated
target-effector conjugate formation and measured LFA
expression (adhesion molecule) which was comparable
between hip fracture patients with and without depres-
sion and healthy controls, suggesting that NK cell ca-
pacity to bind to target cells is not responsible for
compromised NK cell cytotoxicity. These data contra-
dict a previous report linking suppressed NK cell func-
tion in the family members of cancer patients with
reduced conjugate formation (Montelli et al. 2001), but
this may be a reflection of the ages of the two groups
studied. When comparing other aspects of the NK cell
cytotoxic process, we noted significantly lower perforin
content in cells of depressed hip fracture patients. As far
as we are aware, this is the first study to suggest that
psychological distress-induced impairment in NKCC
might be due to reduced perforin expression. The essen-
tial role of perforin in granule exocytosis and hence
NKCC has been confirmed by studies in perforin-
deficient mice, showing an increased susceptibility to-
wards tumours (van den Broek et al. 1996) and ineffi-
cient control of viral challenges (van Dommelen et al.
2006) in these mice due to impairments in NKCC (Kagi
et al. 1994). Interestingly, a study examining the effect
of a psychosocial therapy on psychological responses
reported a reduction in depression scores and also im-
proved NK cell activity by increasing their perforin and
granzyme expression (Li and Kawada 2011).
Our data suggested that elevated cortisol levels in the
depressed hip fracture patients might be a contributing
factor towards impaired NK cell cytotoxicity. Although
raised circulating levels of cortisol did not mediate the
effects of depression on NKCC, our in vitro analyses
with dexamethasone suggest that cortisol is involved,
although potentially contributing separately to both de-
pressive symptoms and reduced NK cell function. In
vitro studies have previously shown a suppressive effect
of dexamethasone on killing by an NK cell line (Bush
et al. 2012; Callewaert et al. 1991; Krukowski et al.
2011) and peripheral blood leukocytes enriched for
NK cells (Holbrook et al. 1983). Here, we confirm that
a physiologically equivalent dose of dexamethasone
a
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Perforin expression in NK cells in hip fracture patients with
depressive symptoms (HF + D; n=19) and without depressive
symptoms (HF; n=11) at 6 weeks and 6 months post-injury. Data
are mean±SEM
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also suppressed NKCC in isolated human NK cells.
Interestingly, a clinical study has reported suppressed
NK cell activity in healthy subjects following an infu-
sion of cortisol, epinephrine and glucagon to mimic the
response to burn injury (Blazar et al. 1986). In addition,
we show a reduction in serum DHEAS levels in the
depressed hip fracture patients. Previous findings have
reported a positive effect of DHEAS on NK cell cyto-
toxicity (Solerte et al. 1999), though we did not find an
association between serum DHEAS and NKCC. Taken
together, our data and the published literature suggest
that increased HPA axis activity in depressed hip frac-
ture patients is contributing to suppressed NK cell ac-
tivity in these patients, although not directly mediating
the association between depression and NK cell
function.
In vitro dexamethasone experiments add further sup-
port for a role of increased HPA axis activity in reduced
NKCC. Reduced intracellular perforin expression was
found here and was also reported previously in NK cells
treated with dexamethasone (Bush et al. 2012).
Furthermore, Mifepristone (a glucocorticoid antagonist)
can augment NK cell cytotoxicity via increased perforin
expression mediated by ERK activation, which can be
blocked by cortisol (Qian et al. 2012). These reports
support our proposal that prolonged exposure of NK
cells to cortisol lowers the expression of perforin,
resulting in a reduced ability of NK cells to induce target
cell lysis. It is possible that high cortisol separately
results in increased depressive symptoms rather than
vice versa, which would explain why depressive symp-
toms, cortisol and NK cell function are all related, but
cortisol level does not statistically mediate the associa-
tion between depression and reduced NK cell function.
In an observational study such as this, we are unable to
determine the direction of causality.
Although we were unable to investigate the molecu-
lar mechanisms underlying suppressed perforin expres-
sion in the NK cells of depressed individuals with higher
serum cortisol levels, previous studies have suggested
that glucocorticoids induce epigenetic modifications
and regulate gene transcription of immune responsive
genes (Mifsud et al. 2011). Glucocorticoids induce re-
duced acetylation at the histone 4 lysine 8 (H4-K8)
position, possibly resulting in reduced expression of
genes such as perforin (Krukowski et al. 2011).
In this study, we have linked psychological distress
with HPA axis activation and suppressed NK cell cyto-
toxicity. However, the HPA axis is not the sole pathway
mediating stress-related immune suppressive effects.
For instance, a study reporting an elevated cortisol level
and suppressed NK cell activity in bereaved women
compared to controls also reported a significant reduc-
tion in NK cell activity in women anticipating bereave-
ment without elevated cortisol levels (Irwin et al. 1988).
Further, in our own work on neutrophil function, de-
pressed patients again had the highest cortisol level and
poorest neutrophil function, but cortisol did not mediate
the relationship between depressive symptoms and neu-
trophil superoxide production (Duggal et al. 2013).
Depression has been associated with sympathetic ner-
vous system activation and release of neuropeptides
(epinephrine, neuropeptide Y), which has a suppressive
effect on NK cell activity (Irwin et al. 1991; Maes et al.
1994) by reducing levels of perforin and granzyme B
(Dokur et al. 2004). Another cortisol-independent
mechanism via opioid peptide release on exposure to
stress is known for reducing NK cell cytotoxicity
(Shavit et al. 1984).
Stress-induced immune dysregulation may persist
even after chronic stress has ablated (Kiecolt-Glaser
et al. 1996). Hip fracture is associated with an increase
in mortality that can persist for years after the fracture.
Recovery after hip fracture is a long process, and only
one third of patients have been reported to return to their
pre-fracture functional status 1 year after the fracture
(Magaziner et al. 2000). We have reported that depres-
sion results in a long-term suppression of NK cell func-
tioning in hip fracture patients. Additionally, we have
also reported that perforin expression in depressed hip
fracture patients did not improve even 6 months post-
surgery.
In conclusion, in this study, we propose that the
development of depression in hip fracture patients
results in long-term impairment in their NK cell
functioning. Our results suggest that therapy to
reduce the incidence of depression in these pa-
tients could not only improve the quality of life
in the elderly after hip fracture but also reduce risk
of life-threatening infections.
Materials and methods
Participants
One hundred one hip fracture patients were recruited
from five hospitals in Birmingham, UK, between 2010
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and 2012. Inclusion criteria were that participants had to
be aged 60 years and over with a hip fracture sustained
4–6 weeks previously but with no chronic immune
disorders or taking any regular medications that might
modify immunity. Additionally, patients must not have
had a previous history of chronic depression. Fifty
healthy older adults were also recruited from the com-
munity as controls. The study was approved by South
Birmingham Local Research Ethics Committee, and all
participants provided written informed consent (study
ref: 09/H1203/80).
Study design
The study was a prospective case-control design with
three groups of older adults: hip fracture patients with or
without depression and healthy older adults. Consent
was gained whilst patients were still in hospital. All
participants completed questionnaires, structured inter-
views and provided a blood sample (40 ml) 4–6 weeks
and 6 months after hip fracture. The blood sample
was used for a broad range of immune function
tests, and for this reason, only 10 ml was available
to NK cell analysis. Thus, it was not always
possible to gain sufficient cells for all analyses,
and the sample size is therefore shown in each
figure legend. Blood samples were taken between
0900 and 1100 hours to minimise any effect of
diurnal variations in steroid levels or immune
function. None of the patients had an infection at
the time of blood sampling. Assays for NK cell
cytotoxicity were performed on the same day as
blood sampling; remaining PBMCs were frozen
down for later NK cell phenotypic analysis. Serum
was frozen for subsequent analysis of adrenal hormone
levels.
Assessment for depressive symptoms
Standard socio-demographic and health behaviour in-
formation were taken, and all medications, prescription
and over-the-counter were recorded by the interviewer.
The psychological status of the participant was assessed
by means of standardised psychometric questionnaires.
The presence of depressive symptomatology was eval-
uated using a Geriatric Depression Scale (Yesavage
et al. 1982), and depression was defined as a GDS score
greater than or equal to 6 on this scale.
Immunostaining for phenotypic analysis of NK cells
Peripheral blood mononuclear cells (PBMCs) were iso-
lated by density centrifugation using Ficoll-Paque™
PLUS (GE Healthcare, Uppsala, Sweden). PBMCs
were frozen down by re-suspending cells in freezing
medium consisting of 10 % DMSO (Sigma-Aldrich,
UK) in heat-inactivated fetal calf serum (Biosera, UK)
and transferring them in small aliquots into cryovials.
The cryovials were transferred into a freezing container
(Mr Frosty, Sigma-Aldrich, UK) containing isopropanol
(VWR International, UK), and the frozen cells were
then stored at −80 °C. Frozen samples were thawed in
a water bath at 37 °C and washed in RPMI 1640.
PBMCs were then resuspended in phosphate-buffered
saline (PBS) at a concentration of 1×106/ml and were
stained with anti-human CD3-FITC (Dako Ltd,
Cambridge, UK; clone UCHT1), CD56-PE (Dako Ltd;
clone C5.9), CD11a-FITC (Dako Ltd; clone MHM24),
CD16-FITC (eBiosciences, Hatfield, UK; clone CB16),
CD57-FITC (BioLegend, London, UK; HCD57) or
NKG2D-PEcy7 (BioLegend; 1D11) for 20 min at
4 °C. Post-incubation, cells were washed and resus-
pended in PBS and transferred into FACS tubes for
flow cytometric analysis using a Cyan™ ADP flow
cytometer (Dako Ltd). Appropriate isotype controls
were used for setting of gates. The CD56dim to
CD56bright ratio was determined on absolute numbers
of cells.
NK cell cytotoxicity
NK cells were isolated from PBMCs by negative selec-
tion using MACS technology (Human NK cell isolation
kit; Miltenyi Biotech, Germany), and purity of isolated
NK cells was assessed by immunostaining for CD56
and flow cytometry. Purity obtained on a routine basis
was >92 %. The MHC class I-deficient NK-sensitive
cell line K562 was used as the target population for NK
cell cytotoxicity (NKCC) assays. K562 cells were ob-
tained from the American Type Culture Collection
(ATCC, Middlesex, UK; ATCC number CCL-243)
and were maintained in medium containing 2 mM L-
glutamine, 100 U/ml penicillin and 100 μg/ml strepto-
mycin (Sigma-Aldrich, Poole, UK) supplemented with
10 % heat-inactivated fetal calf serum (Sera
Laboratories International, Sussex, UK) at 37 °C in a
humidified 5 % CO2 atmosphere. Cells were split one in
three on the day preceding the assay. NKCC was
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assessed by two-colour flow cytometry using an adapted
version of the protocol described by Godoy-Ramirez
and colleagues (Godoy-Ramirez et al. 2000). Briefly,
NK cells and K562 cells in a final effector (E) to target
(T) cell ratio of 10:1 were incubated together in a 96-
well U bottom plate at 37 °C in a humidified 5 % CO2
atmosphere for 2 h. Due to the limited amount of blood
available from hip fracture patients, only one E/T ratio
(10:1) could be performed, though the assay initially
validated over a range of E/T ratios (20:1, 10:1, 5:1 and
2.5:1) and incubation times to establish 2 h as an optimal
time point. To account for spontaneous lysis of target
cells during this period, K562 cells were incubated in
the absence of effector cells. Post-incubation, cells were
pelleted and stained with antibody CD56-PE (Dako Ltd;
clone C5.9). After 20 min of labelling on ice, cells were
washed once in PBS, and the subsequent pellet was re-
suspended in PBS. To detect cell death, sytox blue cell
stain (pre-diluted 1:800 in PBS; Invitrogen, Paisley,
UK) was added to each well, and the cells were trans-
ferred to FACS tubes and samples analysed by flow
cytometry using a Cyan™ ADP flow cytometer (Dako
Ltd). To assess the percentage of lysed target cells
within the sample, NK cells and K562 cells were distin-
guished from one another via staining using anti-CD56
antibody. The cytometry gate was set on K562 target
cells to exclude effector (NK cells) (Fig. 1a), and target
cell death was measured. Results were expressed as %
specific lysis and calculated by the formula:
%Specific lysis ¼ test−spontaneousð Þ=2000½   100
Test represents the percentage of target cells lysed by
NK cells; spontaneous represents the percentage of
target cells lysed in culture in the absence of NK
cells. Post-incubation, immunophenotyping and scat-
ter profiles were used to distinguish between effector
(NK cells), target cells (K562 cells) and conjugates
of both cells.
Measurement of perforin and granzyme B expression
in NK cells
PBMCs (1×106/ml) were stained for extracellular sur-
face markers to identify NK cells CD3-FITC (Dako Ltd;
clone UCHT1) and PE-conjugated CD56 (Dako Ltd;
clone C5.9) for 20 min in the dark at 4 °C. Cells were
washed with PBS and re-suspended in 50 μl of Reagent
A (Fix and Perm kit, Invitrogen) and incubated for
30 min in the dark at 20 °C. Post-fixing, cells were then
washed with PBS and centrifuged at 250×g for 5 min.
The pelleted cells were resuspended in 50 μl of Reagent
B (Fix and Perm kit, Invitrogen) and were stained with
anti-human Perforin-FITC antibody (BioLegend; clone:
Dg9) or with anti-human granzyme-FITC antibody
(BioLegend; clone: GB11) for 30 min in the dark at
20 °C. Finally, the cells were washed and resuspended in
PBS and analysed by flow cytometry (Cyan™ ADP,
Dako). Appropriate isotype controls were used for gate
setting.
Serum cortisol and DHEAS assays
Serum cortisol and DHEAS levels were measured by
ELISA using a commercial kit (IBL international,
Hamburg, Germany) according to the manufacturer’s
instructions. Intra-assay coefficients of variation (CV %)
were 6.7 for cortisol and 4.6 for DHEAS ELISAs.
In vitro dexamethasone treatment of NK cells
NK cells isolated (1×106 cells/ml) from young donors
were incubated in 96-well round bottomed plates in the
presence of water soluble dexamethasone (Sigma-
Aldrich) at 10−5-, 10−7- and 10−9-M concentrations or
distilled water (control) for 18 h. The physiologically
relevant concentration of dexamethasone approximates
to 10−7 M (Bush et al. 2012; Krukowski et al. 2011).
Post-incubation, cells were washed twice with RPMI
1640 medium (Sigma-Aldrich) and NK cells were re-
suspended to 1×106 cells/ml for further analysis.
Annexin V staining to measure apoptosis
Annexin V binds to phosphatidylserine exposed on the
outer leaflet of apoptosis cells and can thus be used to
identify apoptotic cells (Andree et al. 1990). Isolated
NK cells (1×106) were resuspended in 1× Annexin V
Binding buffer (BD Biosciences, UK). Annexin V-FITC
(BD Biosciences, Oxford, UK) was added to the cells,
and after gentle vortexing, the cells were incubated
for 10 min at 4 °C in the dark. Post-staining, the
cells were then transferred into a FACS tube con-
taining 1× Annexin V Binding buffer and were
analysed for Annexin V binding by flow cytometry
(Cyan™ ADP, Dako). NK cell death was also mea-
sured by immunostaining isolated NK cells (1×106)
resuspended in 100 μl of PBS with 10 μl of sytox
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blue cell stain (pre-diluted 1:800 in PBS; Invitrogen)
followed by analysis via flow cytometry.
Assessing NK cell activation status
NK cell activation was assessed by measuring expres-
sion of CD69 and the degranulation marker CD107a.
IsolatedNK cells (1×106/ml) were incubated with K562
cells (1×105/ml) in a final effector (E) to target (T) cell
ratio of 10:1 at 37 °C in a humidified 5 % CO2 atmo-
sphere for 2 h. Post-incubation, cells were washed and
re-suspended in PBS and immunostained using anti-
human CD56-PE antibody (Dako; clone C5.9) and
anti-human CD69-FITC antibody (eBiosciences; clone
FN50) on ice for 20 min in the dark. After which, cells
were washed and resuspended in PBS and analysed for
CD69 positivity by flow cytometry (Cyan™ ADP,
Dako). The percentage of CD69 expressed by 4000
NK cells was recorded.
Granule fusion with the NK cell membrane was
assessed using a slightly modified version of a CD107a
degranulation assay previously described by Alter and
colleagues (Alter et al. 2004). PBMCs (1×106/ml) were
incubated with K562 cells at an E/T ratio of 1:1 in the
presence of 5 μl of anti-CD107a-FITC antibody
(eBiosciences; clone: eBio H4A3) for 1 h at 37 °C in a
humidified 5 % CO2 atmosphere. After 1-h incubation,
6 μg/ml of monensin (Sigma-Aldrich) was added, and
the samples were incubated for a further 2 h. NK cells
(1×106/ ml) incubated alone served as controls. Post-
incubation, the cells were pelleted and resuspended in
PBS and stained with anti-human CD56-PE antibody
(Dako Ltd; clone C5.9) and anti-human CD3-Pacific
blue antibody (BD biosciences; clone: UCHT1) for
20 min at 4 °C in the dark. After which, co-cultured cells
were washed and resuspended in PBS, and CD107a
expression on 4000 NK cells was recorded by flow
cytometry.
Statistical analysis
Univariate ANOVAwith least significant difference post
hoc tests was used to assess differences between the
three groups. Where demographic variables differed
significantly between the groups, analyses were rerun
adjusting for these variables using ANCOVA. Pearson’s
correlations were used to examine associations between
depression score and NK cell function and stress hor-
mone levels. In order to test for potential mediation
between depression group and immune outcomes by
stress hormones, a series of linear regression models
were run. Group (depressed hip fracture, non-
depressed hip fracture, healthy controls) was entered
into the model at step 1 with the immune outcome as
the dependent variable. This was then repeated with the
relevant stress hormone entered at step 2, to examine
effects on the original associations between group and
immune outcome. Where any of these original associa-
tions became non-significant after entering the potential
mediator (stress hormone), mediation was deemed to
have occurred and checked using the Sobel test.
Acknowledgments We are grateful to the following hospital
consultants for their assistance: Professor Sir Keith Porter (Queen
Elizabeth Hospital Birmingham), Mr Martin Goodman (Queen
Elizabeth Hospital Birmingham), Mr Edward Davis (Russell’s
Hall Hospital Dudley) and Mr Sanjay Mistry (Heartlands Hospital
Birmingham).
Funding This research was supported by funding from the
Research Councils UK New Dynamics of Ageing initiative ad-
ministered through the Economic and Social Research Council
(project RES-356-25-0011).
Author contributions NAD, JU and PH recruited patients and
carried out the experimental work; ACP and NAD carried out the
statistical analyses; NAD, ACP and JML contributed to writing the
manuscript and ACP and JML designed the study.
Conflict of interest The authors declare no commercial or fi-
nancial conflict of interest.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use,
distribution, and reproduction in any medium, provided the orig-
inal author(s) and the source are credited.
References
Almeida-Oliveira A, Smith-Carvalho M, Porto LC, Cardoso-
Oliveira J, Ribeiro Ados S, Falcao RR, Abdelhay E,
Bouzas LF, Thuler LC, Ornellas MH (2011) Age-related
changes in natural killer cell receptors from childhood
through old age. Hum Immunol 72(4):319–329. doi:10.
1016/j.humimm.2011.01.009
Alter G, Malenfant JM, Altfeld M (2004) CD107a as a functional
marker for the identification of natural killer cell activity. J
Immunol Methods 294(1–2):15–22
Andree HA, Reutelingsperger CP, Hauptmann R, Hemker HC,
Hermens WT, Willems GM (1990) Binding of vascular
11 Page 12 of 15 AGE (2015) 37: 11
anticoagulant alpha (VAC alpha) to planar phospholipid bi-
layers. J Biol Chem 265(9):4923–4928
Blazar BA, Rodrick ML, O'Mahony JB, Wood JJ, Bessey PQ,
Wilmore DW, Mannick JA (1986) Suppression of natural
killer-cell function in humans following thermal and traumat-
ic injury. J Clin Immunol 6(1):26–36
Borrego F, Alonso MC, Galiani MD, Carracedo J, Ramirez R,
Ostos B, Pena J, Solana R (1999) NK phenotypic markers
and IL2 response in NK cells from elderly people. Exp
Gerontol 34(2):253–265
Boscolo P (2009) Effects of occupational stress and job insecurity
on the immune response. G Ital Med Lav Ergon 31(3):
277–280
Boscolo P, Di Donato A, Di Giampaolo L, Forcella L, Reale M,
Dadorante V, Alparone F, Pagliaro S, Kouri M, Magrini A
et al (2009) Blood natural killer activity is reduced in men
with occupational stress and job insecurity working in a
university. Int Arch Occup Environ Health 82(6):787–794.
doi:10.1007/s00420-008-0374-5
Bush KA, Krukowski K, Eddy JL, Janusek LW, Mathews HL
(2012) Glucocorticoid receptor mediated suppression of
natural killer cell activity: identification of associated
deacetylase and corepressor molecules. Cell Immunol
275(1–2):80–89. doi:10.1016/j.cellimm.2012.02.014
Butcher SK, Killampalli V, Chahal H, Kaya Alpar E, Lord JM
(2003) Effect of age on susceptibility to post-traumatic infec-
tion in the elderly. Biochem Soc Trans 31(2):449–451
Butcher SK, Killampalli V, Lascelles D, Wang K, Alpar EK, Lord
JM (2005) Raised cortisol:DHEAS ratios in the elderly after
injury: potential impact upon neutrophil function and immu-
nity. Aging Cell 4(6):319–324
Callewaert DM, Moudgil VK, Radcliff G, Waite R (1991)
Hormone specific regulation of natural killer cells by cortisol.
Direct inactivation of the cytotoxic function of cloned human
NK cells without an effect on cellular proliferation. FEBS
Lett 285(1):108–110
Camous X, Pera A, Solana R, Larbi A (2012) NK cells in healthy
aging and age-associated diseases. J Biomed Biotechnol
2012:195956. doi:10.1155/2012/195956
Castle SC (2000) Clinical relevance of age-related immune dys-
function. Clin Infect Dis Off Publ Infect Dis Soc Am 31(2):
578–585
Cerwenka A, Lanier LL (2001) Natural killer cells, viruses and
cancer. Nat Rev Immunol 1(1):41–49
Chidrawar SM, Khan N, Chan YL, Nayak L, Moss PA (2006)
Ageing is associated with a decline in peripheral blood
CD56bright NK cells. Immun Ageing I A 3:10
Cullen SP, Martin SJ (2008) Mechanisms of granule-dependent
killing. Cell Death Differ 15(2):251–262
Darko DF, Lucas AH, Gillin JC, Risch SC, Golshan S,
Hamburger RN, Silverman MB, Janowsky DS (1988)
Cellular immunity and the hypothalamic-pituitary axis
in major affective disorder: a preliminary study. Psychiatry
Res 25(1):1–9
Di Lorenzo G, Balistreri CR, Candore G, Cigna D, Colombo A,
Romano GC, Colucci AT, Gervasi F, Listi F, Potestio M et al
(1999) Granulocyte and natural killer activity in the elderly.
Mech Ageing Dev 108(1):25–38
Dokur M, Boyadjieva N, Sarkar DK (2004) Catecholaminergic
control of NK cell cytolytic activity regulatory factors in the
spleen. J Neuroimmunol 151(1–2):148–157
Duggal NA, Upton J, Phillips AC, Hampson P, Lord JM (2013)
Depressive symptoms are associated with reduced neutrophil
function in hip fracture patients. Brain Behav Immun 33:
173–182. doi:10.1016/j.bbi.2013.07.004
Esterling BA, Kiecolt-Glaser JK, Glaser R (1996) Psychosocial
modulation of cytokine-induced natural killer cell activity in
older adults. Psychosom Med 58(3):264–272
Gayoso I, Sanchez-Correa B, Campos C, Alonso C, Pera A,
Casado JG, Morgado S, Tarazona R, Solana R (2011)
Immunosenescence of human natural killer cells. J Innate
Immun 3(4):337–343
Gerra G, Monti D, Panerai AE, Sacerdote P, Anderlini R, Avanzini
P, Zaimovic A, Brambilla F, Franceschi C (2003) Long-term
immune-endocrine effects of bereavement: relationships with
anxiety levels and mood. Psychiatry Res 121(2):145–158
Godoy-Ramirez K, Franck K, Gaines H (2000) A novel method
for the simultaneous assessment of natural killer cell conju-
gate formation and cytotoxicity at the single-cell level by
multi-parameter flow cytometry. J Immunol Methods
239(1–2):35–44
Graham JE, Christian LM, Kiecolt-Glaser JK (2006) Stress, age,
and immune function: toward a lifespan approach. J Behav
Med 29(4):389–400
Haentjens P, Autier P, Barette M, Venken K, Vanderschueren D,
Boonen S (2007) Survival and functional outcome according
to hip fracture type: a one-year prospective cohort study in
elderly women with an intertrochanteric or femoral neck
fracture. Bone 41(6):958–964
Hazeldine J, ArltW, Lord JM (2010) Dehydroepiandrosterone as a
regulator of immune cell function. J Steroid Biochem Mol
Biol 120(2–3):127–136
Hazeldine J, Hampson P, Lord JM (2012) Reduced release and
binding of perforin at the immunological synapse underlies
the age-related decline in natural killer cell cytotoxicity.
Aging Cell 11(5):751–759. doi:10.1111/j.1474-9726.2012.
00839
Holbrook NJ, Cox WI, Horner HC (1983) Direct suppression of
natural killer activity in human peripheral blood leukocyte
cultures by glucocorticoids and its modulation by interferon.
Cancer Res 43(9):4019–4025
Holmes JD, House AO (2000) Psychiatric illness in hip fracture.
Age Ageing 29(6):537–546
Irwin M, Daniels M, Bloom ET, Smith TL, Weiner H (1987a) Life
events, depressive symptoms, and immune function. Am J
Psychiatry 144(4):437–441
Irwin M, Daniels M, Smith TL, Bloom E, Weiner H (1987b)
Impaired natural killer cell activity during bereavement.
Brain Behav Immun 1(1):98–104
IrwinM, Daniels M, Risch SC, Bloom E,Weiner H (1988) Plasma
cortisol and natural killer cell activity during bereavement.
Biol Psychiatry 24(2):173–178
IrwinM, Patterson T, Smith TL, Caldwell C, Brown SA, Gillin JC,
Grant I (1990) Reduction of immune function in life stress
and depression. Biol Psychiatry 27(1):22–30
Irwin M, Brown M, Patterson T, Hauger R, Mascovich A, Grant I
(1991) Neuropeptide Y and natural killer cell activity: find-
ings in depression and Alzheimer caregiver stress. FASEB J
5(15):3100–3107
Jette AM, Harris BA, Cleary PD, Campion EW (1987) Functional
recovery after hip fracture. Arch Phys Med Rehabil 68(10):
735–740
AGE (2015) 37: 11 Page 13 of 15 11
Johnell O, Gullberg B, Allander E, Kanis JA (1992) The apparent
incidence of hip fracture in Europe: a study of national
register sources. MEDOS Study Group. Osteoporos Int
2(6):298–302
Jozuka H, Jozuka E, Takeuchi S, Nishikaze O (2003) Comparison
of immunological and endocrinological markers associated
with major depression. J Int Med Res 31(1):36–41
Kagi D, Ledermann B, Burki K, Seiler P, Odermatt B, Olsen KJ,
Podack ER, Zinkernagel RM, Hengartner H (1994)
Cytotoxicity mediated by T cells and natural killer cells is
greatly impaired in perforin-deficient mice. Nature
369(6475):31–37
Kiecolt-Glaser JK, Glaser R, Shuttleworth EC, Dyer CS, Ogrocki
P, Speicher CE (1987) Chronic stress and immunity in family
caregivers of Alzheimer's disease victims. Psychosom Med
49(5):523–535
Kiecolt-Glaser JK, Glaser R, Gravenstein S, Malarkey WB,
Sheridan J (1996) Chronic stress alters the immune response
to influenza virus vaccine in older adults. Proc Natl Acad Sci
U S A 93(7):3043–3047
Kiecolt-Glaser JK, Loving TJ, Stowell JR, Malarkey WB,
Lemeshow S, Dickinson SL, Glaser R (2005) Hostile marital
interactions, proinflammatory cytokine production, and
wound healing. Arch Gen Psychiatry 62(12):1377–1384
Kronfol Z, Nair M, Goodson J, Goel K, Haskett R, Schwartz S
(1989) Natural killer cell activity in depressive illness: pre-
liminary report. Biol Psychiatry 26(7):753–756
Krukowski K, Eddy J, Kosik KL, Konley T, Janusek LW,
Mathews HL (2011) Glucocorticoid dysregulation of natural
killer cell function through epigenetic modification.
Brain Behav Immun 25(2):239–249. doi:10.1016/j.bbi.
2010.07.244
Law RH, Lukoyanova N, Voskoboinik I, Caradoc-Davies TT,
Baran K, Dunstone MA, D'Angelo ME, Orlova EV,
Coulibaly F, Verschoor S et al (2010) The structural basis
for membrane binding and pore formation by lymphocyte
perforin. Nature 468(7322):447–451. doi:10.1038/
nature09518
Levy SM, Herberman RB, Lee J, Whiteside T, Beadle M, Heiden
L, Simons A (1991) Persistently low natural killer cell activ-
ity, age, and environmental stress as predictors of infectious
morbidity. Nat Immun Cell Growth Regul 10(6):289–307
Li Q, Kawada T (2011) Effect of forest therapy on the human
psycho-neuro-endocrino-immune network. Nihon Eiseigaku
Zasshi 66(4):645–650
Lopez-Verges S, Milush JM, Pandey S, York VA, Arakawa-Hoyt
J, Pircher H, Norris PJ, Nixon DF, Lanier LL (2010) CD57
defines a functionally distinct population of mature NK cells
in the human CD56dimCD16+ NK-cell subset. Blood
116(19):3865–3874. doi:10.1182/blood-2010-04-282301
Maes M, Meltzer HY, Stevens W, Calabrese J, Cosyns P
(1994) Natural killer cell activity in major depression:
relation to circulating natural killer cells, cellular indi-
ces of the immune response, and depressive phenome-
nology. Prog Neuropsychopharmacol Biol Psychiatry
18(4):717–730
Magaziner J, Hawkes W, Hebel JR, Zimmerman SI, Fox KM,
DolanM, Felsenthal G, Kenzora J (2000) Recovery from hip
fracture in eight areas of function. J Gerontol A Biol Sci Med
Sci 55(9):M498–M507
Matsumoto G, Omi Y, Lee U, Nishimura T, Shindo J, Penninger
JM (2000) Adhesion mediated by LFA-1 is required for
efficient IL-12-induced NK and NKT cell cytotoxicity. Eur
J Immunol 30(12):3723–3731
Meyer KC (2005) Aging. Proc Am Thorac Soc 2(5):433–439
Mifsud KR, Gutierrez-Mecinas M, Trollope AF, Collins A,
Saunderson EA, Reul JM (2011) Epigenetic mecha-
nisms in stress and adaptation. Brain Behav Immun
25(7):1305–1315
Montelli TC, Peracoli MT, Gabarra RC, Soares AM, Kurokawa
CS (2001) Familial cancer: depressed NK-cell cytotoxicity in
healthy and cancer affected members. Arq Neuropsiquiatr
59(1):6–10
Moretta L, Bottino C, Pende D, Castriconi R, Mingari MC,
Moretta A (2006) Surface NK receptors and their ligands
on tumor cells. Semin Immunol 18(3):151–158
Nightingale S, Holmes J, Mason J, House A (2001) Psychiatric
illness and mortality after hip fracture. Lancet 357(9264):
1264–1265
Orange JS (2008) Formation and function of the lytic NK-cell
immunological synapse. Nat Rev Immunol 8(9):713–725
Orentreich N, Brind JL, Rizer RL, Vogelman JH (1984) Age
changes and sex differences in serum dehydroepiandroster-
one sulfate concentrations throughout adulthood. J Clin
Endocrinol Metab 59(3):551–555
Padgett DA, MacCallum RC, Sheridan JF (1998) Stress exacer-
bates age-related decrements in the immune response to an
experimental influenza viral infection. J Gerontol A Biol Sci
Med Sci 53(5):B347–B353
Panda A, Arjona A, Sapey E, Bai F, Fikrig E, Montgomery RR,
Lord JM, ShawAC (2009) Human innate immunosenescence:
causes and consequences for immunity in old age. Trends
Immunol 30(7):325–333. doi:10.1016/j.it.2009.05.004
Parker CR Jr, Mixon RL, Brissie RM, Grizzle WE (1997) Aging
alters zonation in the adrenal cortex of men. J Clin
Endocrinol Metab 82(11):3898–3901
Pedersen WA, Wan R, Mattson MP (2001) Impact of aging on
stress-responsive neuroendocrine systems. Mech Ageing
Dev 122(9):963–983
Phillips AC, Carroll D, Burns VE, Ring C, Macleod J, Drayson M
(2006) Bereavement and marriage are associated with anti-
body response to influenza vaccination in the elderly. Brain
Behav Immun 20(3):279–289
Phillips AC, Upton J, Duggal NA, Carroll D, Lord JM (2013)
Depression following hip fracture is associated with in-
creased physical frailty in older adults: the role of the cortisol:
dehydroepiandrosterone sulphate ratio. BMC Geriatr 13:60.
doi:10.1186/1471-2318-13-60
Qian F, Wang X, Zhang L, Chen S, Piecychna M, Allore H,
Bockenstedt L, Malawista S, Bucala R, Shaw AC, Fikrig E,
Montgomery RR (2012) Age-associated elevation in TLR5
leads to increased inflammatory responses in the elderly.
Aging Cell 11(1):104–110. doi:10.1111/j.1474-9726.2011
Ritchie K, Artero S, Beluche I, Ancelin ML,Mann A, Dupuy AM,
Malafosse A, Boulenger JP (2004) Prevalence of DSM-IV
psychiatric disorder in the French elderly population. Br J
Psychiatry 184:147–152
Sansoni P, Cossarizza A, Brianti V, Fagnoni F, Snelli G,
Monti D, Marcato A, Passeri G, Ortolani C, Forti E
et al (1993) Lymphocyte subsets and natural killer cell
11 Page 14 of 15 AGE (2015) 37: 11
activity in healthy old people and centenarians. Blood
82(9):2767–2773
Shavit Y, Lewis JW, Terman GW, Gale RP, Liebeskind JC
(1984) Opioid peptides mediate the suppressive effect of
stress on natural killer cell cytotoxicity. Science 223(4632):
188–190
Shekelle RB, Raynor WJ Jr, Ostfeld AM, Garron DC, Bieliauskas
LA, Liu SC, Maliza C, Paul O (1981) Psychological depres-
sion and 17-year risk of death from cancer. Psychosom Med
43(2):117–125
Smith SM, Vale WW (2006) The role of the hypothalamic-
pituitary-adrenal axis in neuroendocrine responses to stress.
Dialogues Clin Neurosci 8(4):383–395
Smyth MJ, Cretney E, Kelly JM, Westwood JA, Street SE, Yagita
H, Takeda K, van Dommelen SL, Degli-Esposti MA,
Hayakawa Y (2005) Activation of NK cell cytotoxicity.
Mol Immunol 42(4):501–510
Solerte SB, Fioravanti M, Vignati G, Giustina A, Cravello L,
Ferrari E (1999) Dehydroepiandrosterone sulfate enhances
natural killer cell cytotoxicity in humans via locally generated
immunoreactive insulin-like growth factor I. J Clin
Endocrinol Metab 84(9):3260–3267
Trapani JA, Smyth MJ (2002) Functional significance of the
perforin/granzyme cell death pathway. Nat Rev Immunol
2(10):735–747
Tsigos C, Chrousos GP (2002) Hypothalamic-pituitary-adrenal
axis, neuroendocrine factors and stress. J Psychosom Res
53(4):865–871
van den Broek ME, Kagi D, Ossendorp F, Toes R, Vamvakas S,
Lutz WK, Melief CJ, Zinkernagel RM, Hengartner H (1996)
Decreased tumor surveillance in perforin-deficient mice. J
Exp Med 184(5):1781–1790
van Dommelen SL, Sumaria N, Schreiber RD, Scalzo AA, Smyth
MJ, Degli-Esposti MA (2006) Perforin and granzymes have
distinct roles in defensive immunity and immunopathology.
Immunity 25(5):835–848
Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M,
Leirer VO (1982) Development and validation of a geriatric
depression screening scale: a preliminary report. J Psychiatr
Res 17(1):37–49
Zorrilla EP, Luborsky L, McKay JR, Rosenthal R, Houldin A, Tax
A, McCorkle R, Seligman DA, Schmidt K (2001) The rela-
tionship of depression and stressors to immunological assays:
a meta-analytic review. Brain Behav Immun 15(3):199–226
AGE (2015) 37: 11 Page 15 of 15 11
